Position in LLY
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$9,080,885
+$2,073,158 QoQ
Shares Held
7,571
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
#1,310
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grove Bank & Trust holds $25,083,993 across 15 Drug Manufacturers - General names. LLY ranks #1 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,571 | $9,080,885 | |
| 2 | ABBV |
AbbVie Inc.
|
15,353 | $3,863,428 | |
| 3 | JNJ |
Johnson & Johnson
|
15,184 | $3,856,280 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,556 | $1,998,945 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
22,434 | $1,292,646 | |
| 6 | AMGN |
Amgen Inc
|
3,253 | $1,177,976 | |
| 7 | AZN |
Astrazeneca PLC
|
5,776 | $1,095,244 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,271 | $792,278 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,080,885 | 7,571 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $7,007,727 | 7,619 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $8,498,570 | 7,908 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $7,234,766 | 9,482 | Shares | Defined | 2025-10-06 | |
| 2025-06-30 | $7,645,630 | 9,808 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $8,215,326 | 9,947 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $6,213,056 | 8,048 | Shares | Defined | 2025-01-16 | |
| 2024-09-30 | $5,341,332 | 6,029 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $5,345,363 | 5,904 | Shares | Defined | 2024-07-24 | |
| 2024-03-31 | $4,515,279 | 5,804 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $3,341,297 | 5,732 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $3,027,264 | 5,636 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $2,403,522 | 5,125 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $1,767,239 | 5,146 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $2,256,501 | 6,168 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $2,360,131 | 7,299 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $2,334,131 | 7,199 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,047,545 | 7,150 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,917,243 | 6,941 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,561,204 | 6,757 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,520,340 | 6,624 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,240,111 | 6,638 | Shares | Other | 2021-04-23 | |
| 2020-12-31 | $1,122,954 | 6,651 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $919,056 | 6,209 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,032,363 | 6,288 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $847,163 | 6,107 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||